BIHS Statement on NICE Guideline NG238: Cardiovascular disease: risk assessment and reduction, including lipid modification [NG238] Published: 14 December 2023.
Endorsed by the BIHS Guidelines Standing Committee and Executive Committee.
Endorsed by the BIHS Guidelines Standing Committee and Executive Committee.